Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy

Research output: Contribution to journalReview articlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences